Third Metabolomics Study – temporarily on hold
Personalized treatment plans will require addressing the core metabolic abnormalities found in most ME/CFS patients plus the individual metabolic issues found of each patient.
Science in Service of Humanity (SISOH) is currently in the organizing and fundraising phase for AIMS. Funding will be partially through the Gordon Medical Research Center (GMRC), a non-profit funding research in chronic illness. The study is organized in consultation with the Naviaux Lab at UC San Diego. AIMS will be our third metabolomics study looking at how comprehensive metabolomics analysis can be used to evaluate chronic and inflammatory disease, such as CFS/ME, chronic and post-Lyme disease, fibromyalgia, Parkinson’s disease, and mast cell disorders. AIMS builds on our previous studies, also conducted in collaboration with Robert Naviaux at UC San Diego, which demonstrated there is a clear metabolomic profile in patients with CFS/ME.